NCT05647746

Brief Summary

To study whether Somfit is substantially equivalent to the existing approved devices for full polysomnography and home sleep apnea testing

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

December 10, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

February 7, 2024

Status Verified

February 1, 2024

Enrollment Period

3 months

First QC Date

December 1, 2022

Last Update Submit

February 5, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • The AHI difference between the test device (Somfit) and gold standard (PSG)

    AHI is the apnea hypopnea index, main measure of presence/severity of OSA (obstructive sleep apnea). it will test the null hypothesis that Somfit AHI is not equivalent to the AHI reported by PSG

    Data required for the primary outcome measure are generated in the course of single night sleep recording for every participant. Statistical estimation will be performed after completion of all sleep recordings

  • The AHI difference between the test device (Somfit) and predicate device (WatchPAT)

    AHI is the apnea hypopnea index, main measure of presence/severity of OSA (obstructive sleep apnea). it will test the null hypothesis that Somfit AHI is not equivalent to the AHI reported by PSG

    Data required for this primary outcome measure are generated in the course of single night sleep recording for every participant. Statistical estimation will be performed after completion of all sleep recordings

Secondary Outcomes (2)

  • Difference between hypnogram percent agreements between WatchPAT and PSG, and between Somfit and PSG

    Data required for this outcome measure are generated in the course of single night sleep recording for every participant. Statistical estimation will be performed after completion of all sleep recordings

  • Hypnogram percent agreement between Somfit and PSG

    Data required for this outcome measure are generated in the course of single night sleep recording for every participant. Statistical estimation will be performed after completion of all sleep recordings

Other Outcomes (3)

  • Respiratory Event Index (REI) for Somfit

    The measure will be calculated for every participant following a single night sleep recording

  • Oxygen Desaturation Index (ODI) for Somfit

    The measure will be calculated for every participant following a single night sleep recording

  • Average pulse rate (PR) for Somfit

    The measure will be calculated for every participant following a single night sleep recording

Interventions

Each intervention is a separate diagnostic device. They will all be operating at the same time

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 18 years or over
  • Be able to give informed consent
  • Referral for a diagnostic sleep study with indication of suspected sleep disordered breathing or history of diagnosed sleep disordered breathing

You may not qualify if:

  • Less than 18 years of age
  • Unable or not willing to provide informed consent
  • Need for nursing attendance during the time between 9 pm and 9 am
  • Use of any OSA treatments during any part of the PSG study
  • Previous reaction to skin preparation, tapes and electrode gels used at PSG

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SleepMetrics Pty Ltd

Heidelberg, VUC, 3084, Australia

Location

MeSH Terms

Conditions

Sleep Apnea Syndromes

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The sleep technologists who assess the sleep study outcomes will be blinded to the device generating the diagnostic data
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: As the study investigate performances of the diagnostic equipment, the three diagnostic devices can be applied to the single group of patients at the same time
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2022

First Posted

December 12, 2022

Study Start

December 10, 2022

Primary Completion

February 28, 2023

Study Completion

May 31, 2023

Last Updated

February 7, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations